免費咨詢(xún)熱線(xiàn)：
15522676233
達帕菲尼 Dabrafenib Dabrafenib, also known as GSK2118436 , is an orally bioavailable inhibitor of B-raf (BRAF) protein with potential antineoplastic activity.
更新時(shí)間：2023-07-12
廠(chǎng)商性質(zhì)：代理商
維羅非尼 Vemurafenib Also known as PLX4032, RG7204 or RO5185426, is an orally bioavailable, ATP-competitive, small-molecule inhibitor of BRAF(V600E) kinase with potential antineoplastic activity.
更新時(shí)間：2023-07-12
廠(chǎng)商性質(zhì)：代理商
普納替尼 Ponatinib Ponatinib is an orally bioavailable multitargeted receptor tyrosine kinase (RTK) inhibitor with potential antiangiogenic and antineoplastic activities.
更新時(shí)間：2023-07-12
廠(chǎng)商性質(zhì)：代理商
尼羅替尼 Nilotinib Nilotinib, also known as AMN107, is a small-molecule tyrosine kinase inhibitor approved for the treatment of imatinib-resistant chronic myelogenous leukemia.
更新時(shí)間：2023-07-12
廠(chǎng)商性質(zhì)：代理商
微信掃一掃
